RCSB PDB - 5EI4: First domain of human bromodomain BRD4 in complex with inhibitor 8-(5-Amino-1H-[1,2,4]triazol-3-ylsulfanylmethyl)-3-(4-chlorobenzyl)-7-ethyl-3,7-dihydropurine-2,6-dione (original) (raw)
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins.
[Raux, B.](/search?q=citation.rcsb%5Fauthors:Raux, B.), [Voitovich, Y.](/search?q=citation.rcsb%5Fauthors:Voitovich, Y.), [Derviaux, C.](/search?q=citation.rcsb%5Fauthors:Derviaux, C.), [Lugari, A.](/search?q=citation.rcsb%5Fauthors:Lugari, A.), [Rebuffet, E.](/search?q=citation.rcsb%5Fauthors:Rebuffet, E.), [Milhas, S.](/search?q=citation.rcsb%5Fauthors:Milhas, S.), [Priet, S.](/search?q=citation.rcsb%5Fauthors:Priet, S.), [Roux, T.](/search?q=citation.rcsb%5Fauthors:Roux, T.), [Trinquet, E.](/search?q=citation.rcsb%5Fauthors:Trinquet, E.), [Guillemot, J.C.](/search?q=citation.rcsb%5Fauthors:Guillemot, J.C.), [Knapp, S.](/search?q=citation.rcsb%5Fauthors:Knapp, S.), [Brunel, J.M.](/search?q=citation.rcsb%5Fauthors:Brunel, J.M.), [Fedorov, A.Y.](/search?q=citation.rcsb%5Fauthors:Fedorov, A.Y.), [Collette, Y.](/search?q=citation.rcsb%5Fauthors:Collette, Y.), [Roche, P.](/search?q=citation.rcsb%5Fauthors:Roche, P.), [Betzi, S.](/search?q=citation.rcsb%5Fauthors:Betzi, S.), [Combes, S.](/search?q=citation.rcsb%5Fauthors:Combes, S.), [Morelli, X.](/search?q=citation.rcsb%5Fauthors:Morelli, X.)
(2016) J Med Chem 59: 1634-1641
PubMed: 26735842 Search on PubMed
PubMed Abstract:
A midthroughput screening follow-up program targeting the first bromodomain of the human BRD4 protein, BRD4(BD1), identified an acetylated-mimic xanthine derivative inhibitor. This compound binds with an affinity in the low micromolar range yet exerts suitable unexpected selectivity in vitro against the other members of the bromodomain and extra-terminal domain (BET) family. A structure-based program pinpointed a role of the ZA loop, paving the way for the development of potent and selective BET-BRDi probes.
Organizational Affiliation:
Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Marseille (CRCM), UMR 7258; INSERM U1068; Institut Paoli-Calmettes; Aix-Marseille Université, UM105 , 13273 Marseille, France.